JPRN-UMIN000004332已完成1 期
Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer. - Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer.
Tokyo Women's Medical University0 个研究点目标入组 20 人开始时间: 2010年10月6日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Pregnancy or lactation 2.Decision of unsuitableness by principal investigatior 3.Patient with severe underlying disease 4.Patient with severe allergy disease
研究者
相似试验
已完成
不适用
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50
已完成
2 期
A phase II trial of postoperative adjuvant chemotherapy with carboplatin/ docetaxel for the patients completely resected Non Small Cell Lung Cancernon-small cell lung cancerJPRN-UMIN000002425niversity of Occupational and Environmental Health65
已完成
不适用
A randomized phase II trial of postoperative adjuvant therapy with imanitib for 1 Year versus 6 months in patients with gastrointestinal stromal tumorsGastrointestinal stromal tumor (GIST)JPRN-UMIN000000950Kinki GIST Study Group80
招募中
不适用
Feasibility study of postoperative adjuvant therapy using S-1 after curative esophagectomy for esophageal cancerEsophageal cancerJPRN-jRCT1060220042Hirahara Noriyuki45
招募中
不适用
A Phase I/II Trial of combined adjuvant therapy with gemcitabine and cisplatin for resected biliary tract cancerResected biliary tract cancerJPRN-UMIN000004359Shinshu University School of Medicine, Surgery33